A COMPARATIVE TRIAL OF A CONTROLLED-RELEASE FORMULATION OF KETOPROFEN (ORUVAIL) AND A CONVENTIONAL CAPSULE FORMULATION OF KETOPROFEN (ORUDIS) IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP

被引：14

作者：

MORLEY, KD

BERNSTEIN, RM

HUGHES, GRV

BLACK, CM

RAJAPAKSE, CNA

WILSON, L

机构：

[1] W MIDDLESEX UNIV HOSP,ISLEWORTH,ENGLAND

[2] WRIGHTINGTON HOSP,WIGAN,ENGLAND

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 1984年 / 9卷 / 01期

关键词：

D O I：

10.1185/03007998409109555

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：28 / 34

页数：7

共 50 条

[21] A DOUBLE-BLIND COMPARATIVE TRIAL OF SLOW-RELEASE KETOPROFEN TABLETS AND INDOMETHACIN IN ARTHROSIS OF THE HIP AND KNEE
RAMPON, S
SEMAINE DES HOPITAUX, 1983, 59 (46): : 3243 - 3245
[22] SINGLE-DOSE AND MULTIPLE-DOSE BIOAVAILABILITY STUDIES OF A CONTROLLED-RELEASE PSEUDOEPHEDRINE CAPSULE FORMULATION
GRAVES, DA
WOODWORTH, JR
HINSVARK, ON
ROTENBERG, KS
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (04): : 630 - 635
[23] EFFECTS OF A CONTROLLED-RELEASE FORMULATION OF TRAZODONE ON PSYCHOMOTOR AND AUTONOMIC FUNCTIONS IN HEALTHY-VOLUNTEERS - COMPARISON WITH TRAZODONE (CONVENTIONAL FORMULATION), AMITRIPTYLINE AND PLACEBO
LONGMORE, J
BANJAR, W
BRADSHAW, CM
SZABADI, E
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (01) : 97 - 99
[24] COMPARISON OF THE TOLERANCE AND EFFICACY OF KETOPROFEN (ORUVAIL) AND IBUPROFEN (BRUFEN) IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS - A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL
DAVID, C
CLINICAL TRIALS JOURNAL, 1990, 27 (03) : 196 - 202
[25] A COMPARISON OF PLASMA AND SYNOVIAL-FLUID PROFILES OF STANDARD AND CONTROLLED-RELEASE FORMULATIONS OF KETOPROFEN IN PATIENTS WITH RHEUMATOID-ARTHRITIS
MCCREA, JD
TELFORD, AM
KAYE, CM
BOYD, MWJ
CURRENT MEDICAL RESEARCH AND OPINION, 1986, 10 (02) : 73 - 81
[26] Dissolution Testing of a Controlled-Release Capsule Formulation: Challenges and Solutions Using a Semi-Automated Dissolution System
Lo, Lili
Lu, Xujin
Lloyd, David
DISSOLUTION TECHNOLOGIES, 2013, 20 (02): : 6 - 12
[27] Population Pharmacokinetic Analysis of Pregabalin Controlled-Release Formulation in Patients with Partial Seizures and Fibromyalgia
Ma, Guangli
Xie, Rujia
Marshall, Scott
Pitman, Verne
Posner, Holly
Patrick, Jeffrey
Scavone, Joseph
Chew, Marci L.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S24 - S25
[28] KETOPROFEN LYSINE SALT IN A NEW FOAM FORMULATION FOR THE TOPICAL TREATMENT OF TRAUMATIC INJURIES - A CONTROLLED, BETWEEN-PATIENT, CLINICAL-TRIAL
ZERBI, E
PACE, A
DEMARCHI, F
BASSI, F
ARRIGO, A
GARAGIOLA, U
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (06): : 823 - 829
[29] EFFICACY AND TOLERABILITY OF A NEW CONTROLLED-RELEASE FORMULATION OF METOPROLOL - A COMPARISON WITH CONVENTIONAL METOPROLOL TABLETS IN MILD TO MODERATE HYPERTENSION
HOUTZAGERS, JJR
SMILDE, JG
CREYTENS, G
WESTERGREN, G
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 : S39 - S44
[30] Demonstration of the sustained anthelmintic activity of a controlled-release capsule formulation of ivermectin in ewes under field conditions in New Zealand
Gogolewski, RP
Rugg, D
Allerton, GR
Kawhia, D
Barrick, RA
Eagleson, JS
NEW ZEALAND VETERINARY JOURNAL, 1997, 45 (04) : 163 - 166

← 1 2 3 4 5 →